Gedeon Richter PLC
RGEDF · OTC
Market closed$38.57$0.610100 (+1.61%)After hours $38.57 · 0.00%
Key statistics
Previous close$37.96
Open$37.52
Day high$38.57
Day low$31.00
52-week high$45.28
52-week low$27.17
Market cap7.05B
Volume300.00
Average volume643.00
P/E ratio9.82
Forward P/E—
EPS3.93
Dividend yield+5.47%
Market context
Why it moved
RGEDF shares moved higher today, likely buoyed by renewed investor interest after the company was highlighted as a deeply undervalued stock with significant upside potential, drawing attention to its attractive fair value estimate relative to its current market price.
What is happening
Recent company-specific developments and publisher coverage.
marketscreener.com · June 29, 2026Gedeon Richter plc announces Resignation of Péter Cserháti as Member of the Board of Directors, with Effect from 1 July 2026Pearce IP · June 10, 2026Gedeon Richter & Hetero Labs Enter Global Collaboration for Generic Ozempic®Simply Wall Street · May 29, 2026Why You Might Be Interested In Gedeon Richter PLC (BUSE:RICHTER) For Its Upcoming DividendSeeking Alpha · May 19, 2026Gedeon Richter PLC 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:GEDSF) 2026-05-19Investing.com · May 12, 2026Gedeon Richter reports Q1 revenue miss on timing impacts, reiterates full-year outlookFemtech Insider · March 3, 2026Gedeon Richter Acquires Celmatix’s Women’s Health Drug Discovery PortfolioPharmafile · February 17, 2026Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati PharmaceuticalsНовости GxP · February 10, 2026Gedeon Richter to launch new drug for menopause symptom therapy on European market